{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:41:05Z","timestamp":1781649665913,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.clinbiochem.2014.09.018","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T20:30:06Z","timestamp":1412368206000},"page":"55-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["A family with various symptomatology suggestive of Anderson\u2013Fabry disease and a genetic polymorphism of alpha galactosidase A gene"],"prefix":"10.1016","volume":"48","author":[{"given":"Antonino","family":"Tuttolomondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosaria","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Simonetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Miceli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Colomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoriano Della","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Corpora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0005","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of alpha-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0015","first-page":"347","article-title":"Natural history of Fabry disease in females in the Fabry Outcome Survey","volume":"43","author":"European F.O.S. Investigators","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0020","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"10.1016\/j.clinbiochem.2014.09.018_bb0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0030","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00109-005-0656-2","article-title":"Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the alpha-galactosidase A gene in the Czech and Slovak population","volume":"83","author":"Dobrovolny","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1080\/08035320600618809","article-title":"Disease manifestations and X inactivation in heterozygous females with Fabry disease","volume":"95","author":"Maier","year":"2006","journal-title":"Acta Paediatr Suppl"},{"issue":"2","key":"10.1016\/j.clinbiochem.2014.09.018_bb0040","first-page":"113","article-title":"Anderson-Fabry's disease: diagnostic problems, therapeutic relevance, and clinical experience in the treatment of the disease with enzyme replacement therapy in nephropathic patients","volume":"20","author":"Cianciaruso","year":"2003","journal-title":"G Ital Nefrol"},{"issue":"4","key":"10.1016\/j.clinbiochem.2014.09.018_bb0045","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-1331.2010.03227.x","article-title":"Frequency of Fabry disease in patients with small-fibre neuropathy of unknown aetiology: a pilot study","volume":"18","author":"Tanislav","year":"2011","journal-title":"Eur J Neurol"},{"issue":"9647","key":"10.1016\/j.clinbiochem.2014.09.018_bb0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"Zarate","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0055","article-title":"Diagnostic dilemma and delay in Fabry disease: insights from a case series of young female patients","author":"Ellaway","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0009-8981(01)00478-8","article-title":"Fabry disease: enzymatic diagnosis in dried blood spots on filter paper","volume":"308","author":"Chamoles","year":"2001","journal-title":"Clin Chim Acta"},{"issue":"11","key":"10.1016\/j.clinbiochem.2014.09.018_bb0065","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/GIM.0b013e3181bb05bb","article-title":"Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry","volume":"11","author":"Waldek","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0070","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females [Letter]","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"2","key":"10.1016\/j.clinbiochem.2014.09.018_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.gene.2012.06.013","article-title":"X-inactivation in Fabry disease","volume":"505","author":"Elstein","year":"2012","journal-title":"Gene"},{"issue":"1","key":"10.1016\/j.clinbiochem.2014.09.018_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0085","doi-asserted-by":"crossref","first-page":"4859","DOI":"10.1073\/pnas.83.13.4859","article-title":"Human cc-galactosidase A: nucleotide sequence of a cDNA clone encoding the mature enzyme","volume":"83","author":"Bishop","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0090","first-page":"71A","article-title":"Fabry disease: an asymptomatic hemizygote with significant residual a-galactosidase activity","volume":"33","author":"Bishop","year":"1981","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0095","first-page":"30","article-title":"The gene encoding a-galactosidase A and gene rearrangements causing Fabry disease","volume":"102","author":"Kornreich","year":"1989","journal-title":"Trans Assoc Am Phys"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0100","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/nar\/17.8.3301","article-title":"Nucleotide sequence of the human at-galactosidase A gene","volume":"17","author":"Kornreich","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.clinbiochem.2014.09.018_bb0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1756-0500-4-323","article-title":"Genetic screening of Fabry patients with EcoTILLING and HRM technology","volume":"4","author":"Bono","year":"2011","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.clinbiochem.2014.09.018_bb0110","first-page":"790","article-title":"Altarescu G An intronic haplotype in \u03b1 galactosidase A is associated with reduced mRNA expression in males with cryptogenic stroke","volume":"11","author":"Zeevi","year":"2014","journal-title":"Gene"},{"issue":"33","key":"10.1016\/j.clinbiochem.2014.09.018_bb0115","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.2174\/1381612811319330016","article-title":"Anderson Fabry disease: a multiorgan metabolic disease susceptible of treatment","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"33","key":"10.1016\/j.clinbiochem.2014.09.018_bb0120","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.2174\/13816128113199990387","article-title":"Neurological complications of Anderson\u2013Fabry disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"33","key":"10.1016\/j.clinbiochem.2014.09.018_bb0125","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.2174\/13816128113199990352","article-title":"Licata G Anderson\u2013Fabry disease: a multiorgan disease","volume":"19","author":"Tuttolomondo","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"6","key":"10.1016\/j.clinbiochem.2014.09.018_bb0130","first-page":"485","article-title":"Delayed diagnosis of Fabry disease presenting as myocardial ischaemia","volume":"53","author":"Marc\u00ec","year":"2012","journal-title":"Hell J Cardiol"},{"issue":"16\u201317","key":"10.1016\/j.clinbiochem.2014.09.018_bb0135","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.clinbiochem.2012.07.085","article-title":"Novel alpha-galactosidase A mutation in a female with recurrent strokes","volume":"45","author":"Tuttolomondo","year":"2012","journal-title":"Clin Biochem"},{"issue":"10\u201311","key":"10.1016\/j.clinbiochem.2014.09.018_bb0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.clinbiochem.2012.03.015","article-title":"Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease","volume":"45","author":"Colomba","year":"2012","journal-title":"Clin Biochem"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014006973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014006973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:45:03Z","timestamp":1757864703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014006973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":28,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0009912014006973"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.018","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A family with various symptomatology suggestive of Anderson\u2013Fabry disease and a genetic polymorphism of alpha galactosidase A gene","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}